Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium

NCT00310011 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter

Interventions

DRUG: cisplatin
DRUG: gemcitabine hydrochloride
DRUG: paclitaxel
PROCEDURE: conventional surgery

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]